The journal Neuromuscular Disease has published a summary of the FSHD Society’s 2023 scientific conference held in Milan, Italy, this past June. The article was co-authored by Jamshid Arjomand, PhD, chief science officer of the Society; Davide Gabellini, PhD, of Ospedale San Raffaele in Milan, and Nicol Voermans, MD PhD, of Radboud University Medical Center, on behalf of the full IRC program committee. The article is available to download here until January 6, 2024.
Over 240 researchers, clinicians, patients and pharmaceutical company representatives from a wide geographical background participated to hear about the latest developments and breakthroughs in the field. The meeting was structured to provide a mix of basic and clinical research in five sessions:
- Discovery research & genetics;
- Outcome assessments;
- Disease mechanisms & interventional strategies;
- Clinical studies & trial design; and
- Pediatric FSHD.
The article also summarizes keynote talks given by Professor Baziel van Engelen on the importance of incorporating the patient’s voice to help refine and improve basic laboratory and clinical research, and by Dr. Bénédict Chazaud on the role of the immune system in normal
muscle regeneration and in Duchenne muscular dystrophy.